Virtual reality cognitive-behavioural therapy versus cognitive-behavioural therapy for paranoid delusions

Autor: J de Jager, M Berkhof, R van Grunsven, Roos Pot-Kolder, Anton B P Staring, Maarten Vos, E Kooijmans, E C D van der Stouwe, Wim Veling, B Lestestuiver, Catharina E. R. Zandee, E Van't Hag

Publikováno v: Berkhof, M, van der Stouwe, E C D, Lestestuiver, B, van’t Hag, E, van Grunsven, R, de Jager, J, Kooijmans, E, Zandee, C E R, Staring, A B P, Pot-Kolder, R M C A, Vos, M & Veling, W 2021, ' Virtual reality cognitive-behavioural therapy versus cognitive-behavioural therapy for paranoid delusions : a study protocol for a single-blind multi-Centre randomised controlled superiority trial ', BMC Psychiatry, vol. 21, 496, pp. 1-10 . https://doi.org/10.1186/s12888-021-03473-y
BMC Psychiatry
BMC Psychiatry, 21:496. BMC
BMC Psychiatry, 21:496, 1-10. BioMed Central
BMC Psychiatry, Vol 21, Iss 1, Pp 1-10 (2021)

Background Seventy per cent of patients with psychotic disorders has paranoid delusions. Paranoid delusions are associated with significant distress, hospital admission and social isolation. Cognitive-behavioural therapy for psychosis (CBTp) is the p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2ebc7cb0b555e04c29025de3d183597
https://doi.org/10.1186/s12888-021-03473-y

VML 295 (LY-293111), a novel LTB4 antagonist, is not effective in the prevention of relapse in psoriasis

Autor: J M, Mommers, M M, Van Rossum, M E, Kooijmans-Otero, G L, Parker, P C, van de Kerkhof

Publikováno v: The British journal of dermatology. 142(2)

Leukotriene B4 (LTB4) receptor antagonists have been the subject of several studies in the treatment of inflammatory diseases, including psoriasis. A novel oral LTB4 antagonist, VML 295 (LY-293111) has recently been developed and has a pronounced eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f6f9d19f211bce7ef138c66538d1ac01
https://pubmed.ncbi.nlm.nih.gov/10730758

Prediction of kidney failure in long-term survivors of childhood cancer-an opportunity for intervention in follow-up programs.

Autor: Bökenkamp A; Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Kooijmans E; Department of Pediatric Oncology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Publikováno v: Translational pediatrics [Transl Pediatr] 2023 Nov 28; Vol. 12 (11), pp. 1935-1940. Date of Electronic Publication: 2023 Nov 21.